These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 31403913)
1. Loss of BRG1 ( Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913 [TBL] [Abstract][Full Text] [Related]
2. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4). Bookhout C; Bouldin TW; Ellison DW Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065 [TBL] [Abstract][Full Text] [Related]
3. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Ramalingam P; Croce S; McCluggage WG Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868 [TBL] [Abstract][Full Text] [Related]
4. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939 [TBL] [Abstract][Full Text] [Related]
5. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates. Mei L; Alikhan M; Mujacic I; Parilla M; Antic T Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Switch/Sucrose Nonfermenting Complex Proteins and Nestin Expression in a Cohort of Pediatric Central Nervous System Tumors. Wang XQ; Tessier-Cloutier B; Saunders J; Harvey M; Armstrong L; Ng T; Dunham C; Bush JW Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):304-310. PubMed ID: 37036408 [TBL] [Abstract][Full Text] [Related]
8. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1]. Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778 [TBL] [Abstract][Full Text] [Related]
9. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma. Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887 [TBL] [Abstract][Full Text] [Related]
10. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516 [TBL] [Abstract][Full Text] [Related]
11. Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract. Agaimy A; Bertz S; Cheng L; Hes O; Junker K; Keck B; Lopez-Beltran A; Stöckle M; Wullich B; Hartmann A Virchows Arch; 2016 Sep; 469(3):321-30. PubMed ID: 27339451 [TBL] [Abstract][Full Text] [Related]
12. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases. Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994 [TBL] [Abstract][Full Text] [Related]
15. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Schneppenheim R; Frühwald MC; Gesk S; Hasselblatt M; Jeibmann A; Kordes U; Kreuz M; Leuschner I; Martin Subero JI; Obser T; Oyen F; Vater I; Siebert R Am J Hum Genet; 2010 Feb; 86(2):279-84. PubMed ID: 20137775 [TBL] [Abstract][Full Text] [Related]
16. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type. Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327 [TBL] [Abstract][Full Text] [Related]
17. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features. Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490 [TBL] [Abstract][Full Text] [Related]
18. [Expression of SMARCA4(BRG1) and SMARCB1(INI1) in dedifferentiated and undifferentiated endometrial carcinomas and their correlations with clinicopathological features]. Bi R; Yu L; Tu XY; Ge HJ; Cheng YF; Chang B; Cai X; Jiang WH; Yang WT Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):590-595. PubMed ID: 31422588 [No Abstract] [Full Text] [Related]
19. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors. Deisch J; Raisanen J; Rakheja D Pediatr Dev Pathol; 2011; 14(5):353-9. PubMed ID: 21417895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]